Magnetizing diagnostics: Magnetic Gram staining detects bacteria

July 13, 2012

( -- Gram staining of bacteria is a routine diagnostic method of long standing that can be used for initial diagnoses and to simplify the choice of antibiotics. It is a simple way to classify bacteria into two classes—Gram-positive and Gram-negative—under a microscope. In the journal Angewandte Chemie, American researchers have now introduced an improvement to this method: magnetic Gram staining. This allows for the class-specific, automated, magnetic detection and separation of bacteria.

Gram staining was developed about a hundred years ago by Danish bacteriologist Hans Christian Gram. In this technique, bacterial cultures are colored by a stain known as crystal violet, which enters into the murein layer of the bacterial cell walls. Treatment with an iodine-containing solution forms water-insoluble complexes between the crystal violet and iodine. There are two classes of that differ in the structures of their cell walls. A thick murein layer surrounds one class; the others have only a thin one. Whereas subsequent treatment with ethanol dissolves the stain complex out of the thin murein layer, it remains firmly lodged in the thick murein layers. Bacteria whose stain can be washed away in this manner are classified as Gram-negative; those that remain dark purple are Gram-positive.

Scientists working with Ralph Weissleder at Harvard University in Boston (USA) have now developed Gram staining into a magnetic diagnostic technique. To achieve this, they attached a “molecular hook” to the molecules of crystal violet. With this modified dye, the staining process works just as it does with the original. After staining, however, “eyes” that correspond to the “hooks” are used to attach magnetic nanoparticles to the stain. This makes it easy to quantify the bacteria: nuclear magnetic resonance (NMR) instruments detect the magnetization of the nanoparticles.

It is possible to take an NMR measurement before washing with ethanol to obtain the total number of Gram-positive and Gram-negative bacteria, and again after the washing step to determine the concentration of Gram-positive bacteria.

The advantage of this detection method is its high sensitivity. It is possible that samples could be directly magnetized and measured without prior purification or culture of the bacteria. By using the simple but sensitive miniaturized micro-NMR instruments developed by this research group, fast and sensitive on-the-spot diagnosis is conceivable. In addition, the magnetization could be used for the separation of bacteria from the sample.

Explore further: New Nanoparticle Structure Boosts Magnetic Properties

More information: A Magnetic Gram Stain for Bacterial Detection, Angewandte Chemie International Edition,

Related Stories

New Nanoparticle Structure Boosts Magnetic Properties

December 19, 2005

Magnetic nanoparticles have shown promise as contrast-enhancing agents for improving cancer detection using magnetic resonance imaging (MRI), as miniaturized heaters capable of killing malignant cells, and as targeted drug ...

Coming Soon: Tuberculosis Detection with a Chip?

July 29, 2009

( -- Many of the new techniques based on nanotechnology that have been developed for faster and more sensitive detection of pathogens fail in day-to-day clinical use because they require complex sample preparation ...

Recommended for you

A new form of real gold, almost as light as air

November 25, 2015

Researchers at ETH Zurich have created a new type of foam made of real gold. It is the lightest form ever produced of the precious metal: a thousand times lighter than its conventional form and yet it is nearly impossible ...

Getting under the skin of a medieval mystery

November 23, 2015

A simple PVC eraser has helped an international team of scientists led by bioarchaeologists at the University of York to resolve the mystery surrounding the tissue-thin parchment used by medieval scribes to produce the first ...

Moonlighting molecules: Finding new uses for old enzymes

November 27, 2015

A collaboration between the University of Cambridge and MedImmune, the global biologics research and development arm of AstraZeneca, has led researchers to identify a potentially significant new application for a well-known ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.